Prospective Use of Philips iSuite for Interventional Procedures
Launched by MAYO CLINIC · Feb 13, 2018
Trial Information
Current as of November 10, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is a early-stage test of a new MRI-guided tool called the Philips Interventional iSuite. Researchers want to see if this software can help doctors place biopsy or ablation needles more quickly and accurately inside the body during MRI procedures. It’s a single-group feasibility study, meaning there’s no separate comparison group, and the main goal is to learn how well the software works in real procedures and to get doctor feedback.
Who can participate and what to expect: Adults aged 18 to 90 who are already scheduled for a percutaneous MRI-guided procedure (such as a biopsy or ablation) and who are not pregnant may be invited to join. The study is conducted at Mayo Clinic in Rochester and uses standard MRI guidance plus the iSuite software during the procedure. Participants will be followed for up to about three years, with the main focus on how efficiently the needle is placed and how similar the process is to current CT-guided methods. Secondary goals look at how easy the software is to use. The iSuite software is investigational and not yet FDA-cleared, and enrollment is estimated to be about 12 participants.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Patients already scheduled for a percutaneous MR guided procedure
- Exclusion criteria:
- • Pregnant Women
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
David A Woodrum, M.D., Ph.D.
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials